Abstract
To study the cerebrospinal fluid (CSF) adenosine deaminase (ADA) levels in tuberculous meningitis (TBM) and non-TBM -viral meningitis cases and to determine its diagnostic significance as a biochemical marker of TBM infection.The study population comprised two different patient groups. TBM – group I – 28 cases and non-TBM-viral meningitis – 22 cases. These were enrolled consecutively in the study and CSF speci mens were collected from them. ADA estimation was carried out by spectrophotometry.ADA levels (mean±SD) in the TBM and non-TBM groups were 16.46±6.24 U/L and 5.13±2.96 U/L, respectively (highly significant P < 0.001). Using a CSF ADA cut off reference value of >10 IU/L, the test showed a good sensitivity of 82.14% (95% CI 64.41–92.12) and a high specificity of 90.91% (95% CI 72.19–97.47). Positive and negative predictive value and positive and negative likelihood ratios and accuracy of the test in TBM cases were 92% (95% CI 75.03–97.77), 80% (95% CI 60.86–91.13), 9.03 (95% CI 2.38–34.25), 0.19 (95% CI 0.09–0.44) and 86%, respectively.CSF ADA levels are elevated in the TBM cases as compared to the non-TBM – viral meningitis cases with a good sensitivity and a high specificity. It is a simple and inexpensive diagnostic adjunctive test in the rapid and early diagnosis of TBM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
